{"id":448987,"title":"Risk Classification of Good Pharmacovigilance Practices (GVP) Observations (GUI-0063) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T18:10:24.761000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/risk-classification-pharmacovigilance-observations-0063.html?wbdisable=false","snippet":"Risk Classification of Good Pharmacovigilance Practices (GVP) Observations (GUI-0063) (PDF Version - 295 K) Notice Contact Information Our Mandate: To manage and deliver a national compliance and enforcement program for blood and donor semen; cells, tissues and organs; drugs…","rawSnapshotUrl":"/api/snapshots/raw/448987","browseUrl":"https://replay.healtharchive.ca/job-6/20260103181024/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/risk-classification-pharmacovigilance-observations-0063.html?wbdisable=false#ha_snapshot=448987","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}